UY25855A1 - 4,5-azolo-oxindoles útiles en el tratamiento o control de los desórdenes proliferativos celulares - Google Patents

4,5-azolo-oxindoles útiles en el tratamiento o control de los desórdenes proliferativos celulares

Info

Publication number
UY25855A1
UY25855A1 UY25855A UY25855A UY25855A1 UY 25855 A1 UY25855 A1 UY 25855A1 UY 25855 A UY25855 A UY 25855A UY 25855 A UY25855 A UY 25855A UY 25855 A1 UY25855 A1 UY 25855A1
Authority
UY
Uruguay
Prior art keywords
azolo
useful
treatment
lower alkyl
cell proliferative
Prior art date
Application number
UY25855A
Other languages
English (en)
Inventor
Steven Gregory Mischke
Christophe Michoud
Kin-Chun Luk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY25855A1 publication Critical patent/UY25855A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/04—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups one >CH- group, e.g. cyanines, isocyanines, pseudocyanines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

4,5-azolo-oxindoles nuevos con la fórmula (I) (como es el caso de: 8-(3-metoxi-1H-pirrol-2-ilmetilen)-2-fenil-6,8-dihidroxo-oxazolo[4,5e]indol-7-ona) donde R1 es H, OR3, COR3, COOR3, CONR4R5, NR4R5, alquilo inferior, cicloalquilo, heterociclo, arilo, etc; R2 se selecciona entre H, OR3, NR4R5, halogeno, COR3, COOR3, OCOR·, CONR4R5, CN, alquilo inferior opcionalmente sustituido; X significa =N o =C(R5); Y y Z son cada uno independientemente N, O, o S; teniendo en cuenta que el menos uno de Y y Z es N, y si ambos son N entonces pueden ser sustituidos por alquilo inferior y a es un doble enlace oentre Y-C o Z-C, inhiben las quinasas dependientes de ciclina (CDKs), en particular CDK2, y son útiles en el tratamiento o control de los desórdenes proliferativos celulares, en particular el cáncer. Una composición farmacéutica que contiene como ingrediente activo un compuesto de fórmula l y un vehiculo o excipiente farmacéuticamente aceptable.
UY25855A 1998-12-17 1999-12-16 4,5-azolo-oxindoles útiles en el tratamiento o control de los desórdenes proliferativos celulares UY25855A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11261198P 1998-12-17 1998-12-17

Publications (1)

Publication Number Publication Date
UY25855A1 true UY25855A1 (es) 2001-08-27

Family

ID=22344875

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25855A UY25855A1 (es) 1998-12-17 1999-12-16 4,5-azolo-oxindoles útiles en el tratamiento o control de los desórdenes proliferativos celulares

Country Status (18)

Country Link
EP (1) EP1149106B1 (es)
JP (1) JP2002532502A (es)
KR (2) KR100723854B1 (es)
CN (1) CN1159315C (es)
AR (1) AR021693A1 (es)
AT (1) ATE234839T1 (es)
AU (1) AU770060B2 (es)
BR (1) BR9916216A (es)
CA (1) CA2354852C (es)
DE (1) DE69906149T2 (es)
DK (1) DK1149106T3 (es)
ES (1) ES2192878T3 (es)
PE (1) PE20001329A1 (es)
PT (1) PT1149106E (es)
TR (1) TR200101745T2 (es)
UY (1) UY25855A1 (es)
WO (1) WO2000035920A2 (es)
ZA (1) ZA200104269B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
RU2006117635A (ru) 2003-10-24 2007-12-10 Шеринг Акциенгезельшафт (De) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
BRPI0608178A2 (pt) 2005-04-14 2009-11-17 Hoffmann La Roche derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
US9051263B2 (en) 2010-08-25 2015-06-09 Pacific Biosciences Of California, Inc. Functionalized cyanine dyes (PEG)
EP2850086B1 (en) * 2012-05-18 2023-07-05 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes
US9315864B2 (en) 2012-05-18 2016-04-19 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes with sulfonic acid substituents
KR101668074B1 (ko) * 2015-02-12 2016-10-21 전북대학교산학협력단 Ｐｋｒ 저해제를 유효성분으로 포함하는 기관지 천식의 예방 또는 치료용 조성물
US12097261B2 (en) 2021-05-07 2024-09-24 Kymera Therapeutics, Inc. CDK2 degraders and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984930B1 (en) * 1997-05-07 2005-04-06 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
BR9916216A (pt) 2001-09-11
KR100685192B1 (ko) 2007-02-22
AU3037200A (en) 2000-07-03
PE20001329A1 (es) 2000-12-11
ATE234839T1 (de) 2003-04-15
EP1149106A2 (en) 2001-10-31
DE69906149T2 (de) 2003-12-18
ES2192878T3 (es) 2003-10-16
CA2354852A1 (en) 2000-06-22
ZA200104269B (en) 2002-08-26
JP2002532502A (ja) 2002-10-02
KR20060109360A (ko) 2006-10-19
AU770060B2 (en) 2004-02-12
PT1149106E (pt) 2003-06-30
CN1159315C (zh) 2004-07-28
AR021693A1 (es) 2002-07-31
TR200101745T2 (tr) 2002-05-21
WO2000035920A3 (en) 2000-11-23
DK1149106T3 (da) 2003-07-14
CN1330654A (zh) 2002-01-09
DE69906149D1 (de) 2003-04-24
CA2354852C (en) 2008-09-23
WO2000035920A2 (en) 2000-06-22
EP1149106B1 (en) 2003-03-19
KR20010080768A (ko) 2001-08-22
KR100723854B1 (ko) 2007-05-31

Similar Documents

Publication Publication Date Title
AR017852A1 (es) COMPUESTOS DE PIRAZOLO (3,4-b)PIRIDINA Y SUS SALES, UTILES COMO INHIBIDORES DE LAS PROTEINA-QUINASAS DEPENDIENTES DE CICLINA, Y LAS COMPOSICIONESFARMACEUTICAS QUE LOS CONTIENEN, EVENTUALMENTE ASOCIADOS CON UN AGENTE ANTICANCER.
ECSP055864A (es) Derivados sustituidos del pirrolo-pirazol como inhibidores de la quinasa
AR040047A1 (es) 1-(aminoalquil)-3-sulfonilazaindoles como ligandos de la 5-hidroxitriptamina-6
UY25855A1 (es) 4,5-azolo-oxindoles útiles en el tratamiento o control de los desórdenes proliferativos celulares
BR9807305A (pt) Pirido [2,3-d] pirimidinas e 4-aminopirimidinas como inibidores de proliferação celular.
PA8501801A1 (es) Inhibidores triciclicos de polimerasas (adp - polirribosas)
TR200003429T2 (tr) Hücresel çoğalma inhibitörleri olarak bisiklik pirimidinler ve bisiklik 3,4-dihidropirimidinler.
EA200100764A1 (ru) Трициклические ингибиторы поли(adp-рибозо) полимераз
BR0016420A (pt) Aminotiazóis inibidores de cinases dependentes de ciclinas
AR040566A1 (es) Derivados de 1-heterociclilalquil 3- sulfonilazaindol o azaindazol como ligandos de 5 hidroxitriptamina-6
MXPA03006863A (es) Derivados de oxazolilpirazol com inhibidores de cinasa.
PE20050081A1 (es) Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas
PE20070752A1 (es) Triazolopiridazinas como moduladores de quinasa
PE20060775A1 (es) Derivados de pirrolidilo de compuestos heteroaromaticos como inhibidores de fosfodiesterasa
ATE373653T1 (de) Pyrimidine verbindungen
PE20090511A1 (es) Imidazopiridinonas
ECSP088324A (es) 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas
PE20080704A1 (es) Inhibidores ns5b del virus hepatitis c de indolobenzazepina fusionados a ciclopropilo
AR047531A1 (es) Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa
AR037906A1 (es) Derivados de indolilalquilamina como ligandos de 5-hidroxitriptamina-6
AR026974A1 (es) N-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]-carboxamidas, utiles como inhibidores de cinasas dependientes de ciclina, y las composicionesfarmaceuticas que los contienen
WO2003022805A3 (en) Heterocycle substituted purines as antiproliferative agents
ATE233754T1 (de) Diphenyl-piperidin derivate
AR029214A1 (es) Compuestos inhibidores de fosfodiesterasa - 4: 8 - arilquinolinas sustituidas, composiciones farmaceuticas, metodo de tratamiento que las utiliza
AR022413A1 (es) Utilizacion de derivados de piridazino(4,5-b)indol-1-acetamida, para la preparacion de medicamentos destinados a las enfermedades del sistema nerviosocentral

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20091109